Author: Anonymous,
Title: Cancer Therapy Doesn't Diminish Vaccine Efficacy Cord-id: vl91cwat Document date: 2021_1_1
ID: vl91cwat
Snippet: Patients with cancer are at high risk for complications and death from COVID-19 infections, but vaccination offers patients with solid tumors strong protection against SARS-CoV-2, including the Delta variant. Patients with hematologic malignancies, however, are less likely to mount a strong immune response to vaccination, possibly due to the natural history of the disease and to B cell-depleting therapies that affect antibody responses.
Document: Patients with cancer are at high risk for complications and death from COVID-19 infections, but vaccination offers patients with solid tumors strong protection against SARS-CoV-2, including the Delta variant. Patients with hematologic malignancies, however, are less likely to mount a strong immune response to vaccination, possibly due to the natural history of the disease and to B cell-depleting therapies that affect antibody responses.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date